Corey J. Langer, MD, Professor of Medicine, Hematology/Oncology Division, University of Pennsylvania, Abramson Cancer Center, discusses recent advancements in treating ALK mutation in patients with non-small cell lung cancer.
For more resources and information regarding targeted therapies in cancer: [ Ссылка ]
Ещё видео!